Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1

•

0 likes•7 views

Dr. Richard A May, MD, PhD, D.H.Sc. Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1

CERTIFICATE OF ATTENDANCE
University of Cincinnati
certifies that
Richard A May, MD, PhD
has participated in the educational activity
Antimicrobial Stewardship: Antimicrobial Prophylaxis in the Surgical Setting: Practical
Application in Smaller Hospitals - Module 2
on
February 19, 2012
and is awarded 1.00 AMA PRA Category 1 Credits™.
John R. Kues, Ph.D.
Associate Dean,
Continuous Professional
Development
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME)
to provide continuing medical education for physicians.
The University of Cincinnati designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Brandon Jonseck completed this activity on 11/20/2020 through Stanford Medical School. Overview Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine at the Stanford University School of Medicine. Experts discuss the use of immunomodulator therapies for treatment of COVID-19. Discussed hospital updates, Medical Staff updates. Flu vaccination requirements for staff shared. Preparations are in place for the respiratory virus season. Rapid testing requirements. Other topics discussed include immunomodulators for treatment of COVID-19. Talked about Tocilizumab trial for the treatment of COVID-19, NIH ACTT trial and Blaze 1 trial. Also discussed the WHO Solidarity Trial. Remdesivir is the first FDA approved treatment for COVID-19. Describe the strategy for ongoing BLAZE-1 clinical trial. Credits AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours) Target Audience Specialties - All Specialties Objectives At the conclusion of this activity, participants should be able to: Evaluate current clinical trials taking place in order to determine the effectiveness of immunomodulators for treating COVID-19 in the near future. Accreditation The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Stanford HAI COVID19 - Brandon Jonseck

Brand Jonseck

Brandon L. Jonseck, MBA completed on Thursday, November 12, 2020, 12:00 PM PST Overview Sponsored by the Stanford University School of Medicine. Presented by the Department of Stanford Institute for Human-Centered Artificial Intelligence (HAI) at the Stanford University School of Medicine. Scholars from across disciplines will discuss their research using AI, data science and/or informatics to help us understand how we emerge from the COVID crisis. Session Topics: New Models for Financing Vaccine Trials; A High-Resolution Assessment of COVID Infection in the Bay Area; and Leveraging Machine Learning in Strategy on COVID-19. Part of the COVID + AI: The Road Ahead Conference. Only session III of the conference is accredited for CME. Credits AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours) Target Audience Specialties - All Specialties Objectives At the conclusion of this activity, participants should be able to: Examine critical decision points for the medical road ahead relating to: COVID-19, key trends to watch, some alternate options related to vaccine creation, Bay Area COVID-related outcomes, and how AI may (and may not) be able to help local, national, and global decision-makers in the months ahead. Review the status of some ongoing medical trials being run in the Bay Area. Accreditation The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation The Stanford University School of Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ResumeStacie Lahr

Acupuncture Blog Chicago: Healthcare a Prescription for Change

painstakingsled66

Beyond Implementation of Plant Clinics to Sustainably Strengthen Plant Health...FARA - Forum for Agricultural Research in Africa

Patient engagement in the digital era

Dr. Reni Thomas

Janey Wood Resume 2016Janey Wood, RN, MSN

Krauskopf Fehr Nonpf 2010 Poster

Juliana van Olphen Fehr

2011/2012 Always Event℠ Challenge Grant Recipient Project OverviewsPicker Institute, Inc.

bioterror certificateNireshan Naidoo

CMS-Proposed Antibiotic Stewardship Rules: What You Need to Know

PYA, P.C.

University of Pennsylvania - Self management education and support for patien...

Brand Jonseck

Arab Health Congress 2017 CME Conference Brochure (JAN)Cynthia Makarutse

What's hot

Gastroenterology rotation pharmaceutical care N 83

M. Luisetto Pharm.D.Spec. Pharmacology

Impact on infection control preparadness and cancer patients

Zain Abidin

Certificate Neurology Report 63rd Annual Meeting of the American Academy of N...

Dr. Richard May MD, PhD, DHSc.

The Future Role of the Medical Assistant in Effective Care Teams

CHC Connecticut

Nurse Care Manager 2Stanley Hess

Fredericks 2

Jodi Beck Fredericks

Jodi fredericks presentation for aach

Jodi Beck Fredericks

Jodi fredericks presentation for aachmkash2

Jodi Fredericks 2 AACH ppt

Jodi Beck Fredericks

Stanford immunomodulators for treatment of covid19 - brandon jonseck

Brand Jonseck

Stanford HAI COVID19 - Brandon Jonseck

Brand Jonseck

ResumeStacie Lahr

Acupuncture Blog Chicago: Healthcare a Prescription for Change

painstakingsled66

Beyond Implementation of Plant Clinics to Sustainably Strengthen Plant Health...FARA - Forum for Agricultural Research in Africa

Patient engagement in the digital era

Dr. Reni Thomas

Janey Wood Resume 2016Janey Wood, RN, MSN

Krauskopf Fehr Nonpf 2010 Poster

Juliana van Olphen Fehr

2011/2012 Always Event℠ Challenge Grant Recipient Project OverviewsPicker Institute, Inc.

What's hot (18)

Gastroenterology rotation pharmaceutical care N 83

Impact on infection control preparadness and cancer patients

Certificate Neurology Report 63rd Annual Meeting of the American Academy of N...

The Future Role of the Medical Assistant in Effective Care Teams

Nurse Care Manager 2

Fredericks 2

Jodi fredericks presentation for aach

Jodi Fredericks 2 AACH ppt

Stanford immunomodulators for treatment of covid19 - brandon jonseck

Stanford HAI COVID19 - Brandon Jonseck

Resume

Acupuncture Blog Chicago: Healthcare a Prescription for Change

Beyond Implementation of Plant Clinics to Sustainably Strengthen Plant Health...

Patient engagement in the digital era

Janey Wood Resume 2016

Krauskopf Fehr Nonpf 2010 Poster

2011/2012 Always Event℠ Challenge Grant Recipient Project Overviews

Similar to Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1

bioterror certificateNireshan Naidoo

CMS-Proposed Antibiotic Stewardship Rules: What You Need to Know

PYA, P.C.

University of Pennsylvania - Self management education and support for patien...

Brand Jonseck

Arab Health Congress 2017 CME Conference Brochure (JAN)Cynthia Makarutse

Running head BLESSED HEALTHCARE FACILITY MARKETING PLAN .docx

toddr4

Running head: BLESSED HEALTHCARE FACILITY MARKETING PLAN 1 BLESSED HEALTHCARE FACILITY MARKETING PLAN 11 Blessed Healthcare Facility Marketing Plan Marilyn Diaz Healthcare Marketing – MAR3712 Professor Christos Christou Florida National University June 9th, 2019 Abstract Blessed Healthcare Facility is a newly emerging healthcare center located in Miami. This is a privately-owned hospital, which is administered and managed according to the Scheme of the Management approved by the Order of the High Court. This facility a total of 120 beds with 100 in-patient beds and 20 daycare beds. The inpatient specialties care includes gynecology, general surgery, and general medication. These are just but a few services being offered by this healthcare facility. Other services being offered include the Day Surgery; Chaplaincy services; physiotherapy and pharmaceutical services; radiology and the laboratory services; dietetic services, which are involving the provision of the nutritional assessment, education, and assessing the patients based on their nutritional status; and the consultant out-patient clinics. There is also service related to the continence management, control of the infections, palliative care as and the management of pain; and the clinical nurse's specialists in common illness such as diabetes. Blessed Healthcare Facility Marketing Plan Analysis of the Services With regard to the Consultant Out-Patient Clinics, the goal of this facility is to move closer to home. This is aimed at adhering to the hospital policy which recommends for closer movement to home by the children specialist of this facility to ensure that the general pediatrics outpatient services are effectively provided. This approach is aimed at reducing the non-attendance during appointments. It also ensures that services are provided to more accessible regions thus helping in the creation of new physical clinic capacity. The goal of offering such kind of services is to help in increasing the number of pediatrics who are brought to the facility for clinic services (Hazel & Kussel, 2019). With regard to Diagnostic Radiological and Laboratory services, there are pathological tests as well as x-ray examinations. The radiology department is providing high-quality diagnostic service to both in and outpatients. There are also radiology services for the Daycare, and these services are aimed at helping to diagnose the treatment. This, therefore, implies that most of the tests are done within the facility and patients are not referred to other facilities for laboratory procedures. Appointments are also allowed for the patients who are wishing to do so. On physiotherapy services, the hospital has a staff who is experienced in the treatment of both in and out-patients by ensuring that patients are safe to achieve the optimum potential within the shortest time possible. Physiotherapists in this facility are .

Rush University - Pandemic Flu

James Atkinson

PDFMailerLisa Burkett

Prophylactic antibiotics

Rahma Mohammed

Penn Medicine - Sleep in psychiatric disorders - University of Pennsylvania -...

Brand Jonseck

SAGES Certificate-Performance Analysis in Minimally Invasive Surgery

Dr Hamid Sain MBBS(Ad.)FRCSEd

Patient Safety: Paradigm shift of modern healthcare delivery and research

International Journal of Medical Sciences and Nursing Research

Article Type: Editorial Title: Patient Safety: Paradigm shift of modern healthcare delivery and research Year: 2022; Volume: 2; Issue: 1; Page No: 1 – 2 Author: Dr. Mohammed Imran 10.55349/ijmsnr.20222112 Affiliation: Associate Professor, Medical Pharmacology, College of Medicine and Health Sciences, Sohar, National University of Science and Technology, Sultanate of Oman. Email ID: imran@nu.edu.om Article Summary: Submitted : 10-February-2022 Revised : 26-February-2022 Accepted : 12-March-2022 Published : 31-March-2022

The ROI of Avoiding Antibiotic Overuse

PYA, P.C.

PYA Principal J. Michael Keegan, MD, recently presented “Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The presentation focused on the importance of antibiotic stewardship programs (ASP) for population health. The presentation explained: Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria. Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs. What constitutes a successful ASP.

Npsf webcast psaw_live_slides_v1

Jordan Rivera

$Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...$ $Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...$

Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...

Carevive

The target audiences for these activities are hematologists, medical oncologists, pulmonologists, pathologists, physician assistants, nurse practitioners, registered nurses, oncology nurses, nurse navigators, palliative/symptom management teams who care for patients with chronic lymphocytic leukemia (CLL) and quality administrators responsible for their cancer center’s adherence to value-based care delivery models.

University of Pennsylvania Medical School - Saving lives in the opioid crisis...

Brand Jonseck

MEM -GWU 2017 admission

Dr.Venugopalan Poovathum Parambil

Diagnostic Laparoscopy SAGES Certificate

Dr Hamid Sain MBBS(Ad.)FRCSEd

Rush University - SARS

James Atkinson

Edcuation on infection control

Society for Microbiology and Infection care

Diabetes Ev Doc 2013Dr Leslie Jackowski

Similar to Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1 (20)

bioterror certificate

CMS-Proposed Antibiotic Stewardship Rules: What You Need to Know

University of Pennsylvania - Self management education and support for patien...

Arab Health Congress 2017 CME Conference Brochure (JAN)

Running head BLESSED HEALTHCARE FACILITY MARKETING PLAN .docx

Rush University - Pandemic Flu

PDFMailer

Prophylactic antibiotics

Penn Medicine - Sleep in psychiatric disorders - University of Pennsylvania -...

SAGES Certificate-Performance Analysis in Minimally Invasive Surgery

Patient Safety: Paradigm shift of modern healthcare delivery and research

The ROI of Avoiding Antibiotic Overuse

Npsf webcast psaw_live_slides_v1

$Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...$ $Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...$

Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...

University of Pennsylvania Medical School - Saving lives in the opioid crisis...

MEM -GWU 2017 admission

Diagnostic Laparoscopy SAGES Certificate

Rush University - SARS

Edcuation on infection control

Diabetes Ev Doc 2013

Recently uploaded

The Docs PPG - 30.05.2024.pptx..........

TheDocs

Immunity to Veterinary parasitic infections power point presentation

BeshedaWedajo

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

SasikiranMarri

CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations. Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences. The Promise: CRISPR offers exciting possibilities: Gene Therapy: Correcting genetic diseases like cystic fibrosis. Agriculture: Engineering crops resistant to pests and harsh environments. Research: Studying gene function to unlock new knowledge. The Peril: Ethical concerns demand attention: Off-target Effects: Unintended DNA edits can have unforeseen consequences. Eugenics: Misusing CRISPR for designer babies raises social and ethical questions. Equity: High costs could limit access to this potentially life-saving technology. The Path Forward: Responsible development is crucial: International Collaboration: Clear guidelines are needed for research and human trials. Public Education: Open discussions ensure informed decisions about CRISPR. Prioritize Safety and Ethics: Safety and ethical principles must be paramount. CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)

What Are Homeopathic Treatments for Migraines.pdf

Dharma Homoeopathy

A Community health , health for prisoners

Ahmed Elmi

Medical Technology Tackles New Health Care Demand - Research Report - March 2...

pchutichetpong

M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028. According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.” There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation. The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs. In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.

ABDOMINAL COMPARTMENT SYSNDROME

Rommel Luis III Israel

Preventing Pickleball Injuries & Treatment

LAB Sports Therapy

Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...

ILC- UK

The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer. Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer. The speakers included: Professor Orazio Schillaci, Minister of Health, Italy Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden

the IUA Administrative Board and General Assembly meeting

ssuser787e5c1

Navigating the Health Insurance Market_ Understanding Trends and Options.pdf

Enterprise Wired

Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤

ranishasharma67

Anatomy and Physiology Chapter-16_Digestive-System.pptx

shanicedivinagracia2

India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...

Kumar Satyam

According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market. Growing Prevalence of Lifestyle Diseases The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.

CANCER CANCER CANCER CANCER CANCER CANCER

KRISTELLEGAMBOA2

Secret Tantric VIP Erotic Massage London

Secret Tantric - VIP Erotic Massage London

HEAT WAVE presented by priya bhojwani..pptx

priyabhojwani1200

Telehealth Psychology Building Trust with Clients.pptx

The Harvest Clinic

Antibiotic Stewardship by Anushri Srivastava.pptx

AnushriSrivastav

Stewardship is the act of taking good care of something. Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels. ACCORDING TO apic.org, Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. ACCORDING TO pewtrusts.org, Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate According to WHO, Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis. Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance. According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites VISION Being proactive Supporting optimal animal and human health Exploring ways to reduce overall use of antimicrobials Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way GOAL to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come. being to preserve human and animal health and the effectiveness of antimicrobial medications. to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory to prevent antimicrobial overuse, misuse and abuse. to minimize the developme

Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...

Dr. David Greene Arizona

Recently uploaded (20)

The Docs PPG - 30.05.2024.pptx..........

Immunity to Veterinary parasitic infections power point presentation

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

What Are Homeopathic Treatments for Migraines.pdf

A Community health , health for prisoners

Medical Technology Tackles New Health Care Demand - Research Report - March 2...

ABDOMINAL COMPARTMENT SYSNDROME

Preventing Pickleball Injuries & Treatment

Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...

the IUA Administrative Board and General Assembly meeting

Navigating the Health Insurance Market_ Understanding Trends and Options.pdf

Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤

Anatomy and Physiology Chapter-16_Digestive-System.pptx

India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...

CANCER CANCER CANCER CANCER CANCER CANCER

Secret Tantric VIP Erotic Massage London

HEAT WAVE presented by priya bhojwani..pptx

Telehealth Psychology Building Trust with Clients.pptx

Antibiotic Stewardship by Anushri Srivastava.pptx

Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...

Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1

1. CERTIFICATE OF ATTENDANCE University of Cincinnati certifies that Richard A May, MD, PhD has participated in the educational activity Antimicrobial Stewardship: Antimicrobial Prophylaxis in the Surgical Setting: Practical Application in Smaller Hospitals - Module 2 on February 19, 2012 and is awarded 1.00 AMA PRA Category 1 Credits™. John R. Kues, Ph.D. Associate Dean, Continuous Professional Development The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Cincinnati designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1

Recommended

Recommended

More Related Content

What's hot

What's hot (18)

Similar to Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1

Similar to Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1 (20)

Recently uploaded

Recently uploaded (20)

Certificate Antimicrobial Stewardship Module 2 - Antimicrobial Prophylaxis in the Surgical Setting 87297 13905-1